title: A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.
abstract: A selective bi-site ELISA assay procedure for quantification of Lp[a] lipoprotein in human plasma based on linkage of apo[a] to apoB is described. The lipoproteins referred to as apo[a]:B were captured by a mixture of two anti-apo[a] monoclonal antibodies (K07, K09) and were revealed by a mixture of six anti-apoB monoclonal antibodies coupled to peroxidase. Since apo[a] and plasminogen have striking similarities in protein structure, the selective binding of Lp[a]:B in our assay depended upon the marked difference in affinity of the K07 and K09 mixture for Lp[a]:B (Kd = 0.32 x 10(-10) M) versus plasminogen (Kd = 0.47 x 10(-7)M). The high sensitivity (the Lp[a]:B working range 0.06-0.40 micrograms/ml) and the use of anti-apoB as antibody tracer added to the selectivity of the assay. The expression of K07 and K09 epitopes determined by competitive inhibition method and the reactivity of Lp[a]:B particles measured by bi-site ELISA were similar on individual lipoproteins, independent to their plasma levels. The assay is precise, and intra- and interassay coefficients of variation were 4.7% and 9.6%, respectively. It yields quantitative Lp[a]:B values that correlate highly with Lp[a] levels obtained by electroimmunoassay with polyclonal antibody (r = 0.73) or with Lp[a] levels measured by the other bi-site ELISA using only K07 and K09 antibodies (r = 0.96). However, upon analyzing each individual plasma with an arbitrary Lp[a]-cut off of 15 mg/dl, evidence of the qualitative aspect of the lipoprotein was obtained. The group with Lp[a] less than 15 mg/dl had higher frequency of subjects (65%) with the ratio Lp[a]/Lp[a]:B above 1.5.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service de Recherche sur les Lipoprotéines et l'Athérosclérose, Institut Pasteur de Lille, France.
authors.forename: N
authors.initials: N
authors.lastname: Vu Dac
authors.forename: H
authors.initials: H
authors.lastname: Mezdour
authors.forename: H J
authors.initials: HJ
authors.lastname: Parra
authors.forename: G
authors.initials: G
authors.lastname: Luc
authors.forename: I
authors.initials: I
authors.lastname: Luyeye
authors.forename: J C
authors.initials: JC
authors.lastname: Fruchart
mesh_terms: D000911:Antibodies, Monoclonal; D001054:Apolipoproteins A / Q000235:genetics / Q000276:immunology; D001055:Apolipoproteins B / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007118:Immunoassay; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood*; D011110:Polymorphism, Genetic; D011487:Protein Conformation
chemical_list: D000911:Antibodies, Monoclonal; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D017270:Lipoprotein(a); D008074:Lipoproteins